3 Israeli biomed cos fall sharply after Nasdaq IPOs
– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. – The shares of three Israeli biomedical companies that completed their IPOs last Wednesday More...
Tuesday 02 March, 2021
- The Milky Way may be swarming with planets with oceans and continents like here on Earth
- Israeli Video Startup Kaltura Looks to $1 Billion IPO
- Compass Real Estate Platform Going Public In Spite of Losses
- Israel's Wiz Cloud Security Is Now a Unicorn With $1 Billion Valuation
- Only Ten Countries Have Full Equal Rights for Women